Bio Essence Corporation
BIOE · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -47.2% | 1,067.8% | -85% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 70% | 65.1% | 92.8% | 72.4% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 10% | 23.6% | -924.3% | -18.1% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 9.5% | 23.1% | -927.3% | -18.7% |
| EPS Diluted | 0 | 0.002 | -0.005 | -0.001 |
| % Growth | -81.3% | 129.6% | -671.4% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |